ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/11689293

Cancer Lett. 2001 Dec 28 174 2 173-8

Download in:

View as

General Info

PMID
11689293